Literature DB >> 21537548

Methotrexate-induced intestinal mucositis delays gastric emptying and gastrointestinal transit of liquids in awake rats.

Pedro M G Soares1, Lorena O Lopes, José Maurício S C Mota, José Nelson Belarmino-Filho, Ronaldo A Ribeiro, Marcellus Henrique L P de Souza.   

Abstract

CONTEXT: Methotrexate and other anticancer agents can induce intestinal mucositis, which is one of the most common limiting factor that prevent further dose escalation of the methotrexate.
OBJECTIVES: To evaluate the gastric emptying and gastrointestinal transit of liquids in methotrexate-induced intestinal mucositis.
METHODS: Wistar rats received methotrexate (2.5 mg/kg/day for 3 days, subcutaneously) or saline. After 1, 3 and 7 days, sections of duodenum, jejunum and ileum were removed for assessment of epithelial damage and myeloperoxidase activity (biochemical marker of granulocyte infiltration). Others rats were pre-treated with methotrexate or saline, gavage-fed after 3 or 7 days with a standard test liquid meal, and sacrificed 10, 20 or 30-min later. Gastric and small intestine dye recoveries were measured by spectrophotometry.
RESULTS: After 3 days of methotrexate, there was an epithelial intestinal damage in all segments, with myeloperoxidase activity increase in both in duodenum and ileum. Seven days after methotrexate, we observed a complete reversion of this intestinal damage. There was an increase in gastric dye recoveries after 10, 20, and 30-min post-prandial intervals after 3 days, but not after 7 days, of methotrexate. Intestine dye recoveries were decreased in the first and second segments at 10 min, in the third at 20 min, and in the second and third at 30 min, only after 3 days of methotrexate treatment.
CONCLUSION: Methotrexate-induced intestinal mucositis delays gastric emptying and gastrointestinal transit of liquids in awake rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537548     DOI: 10.1590/s0004-28032011000100016

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  5 in total

Review 1.  Nutritional screening and assessment in inflammatory bowel disease.

Authors:  Arshdeep Singh; Catherine Wall; Arie Levine; Vandana Midha; Ramit Mahajan; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2022-01-15

2.  Characterization of low active ghrelin ratio in patients with advanced pancreatic cancer.

Authors:  Tomofumi Miura; Shuichi Mitsunaga; Masafumi Ikeda; Izumi Ohno; Hideaki Takahashi; Hidetaka Suzuki; Ai Irisawa; Takeshi Kuwata; Atsushi Ochiai
Journal:  Support Care Cancer       Date:  2018-05-18       Impact factor: 3.603

3.  IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.

Authors:  R Guabiraba; A G Besnard; G B Menezes; T Secher; M S Jabir; S S Amaral; H Braun; R C P Lima-Junior; R A Ribeiro; F Q Cunha; M M Teixeira; R Beyaert; G J Graham; F Y Liew
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

4.  Effects of nimesulide on the small intestine mucositis induced by methotrexate in rats.

Authors:  Aynur Arslan; Adalet Ozcicek; Bahadir Suleyman; Taha Abdulkadir Coban; Ferda Keskin Cimen; Hatice Sevim Nalkiran; Mehmet Kuzucu; Durdu Altuner; Nihal Cetin; Halis Suleyman
Journal:  Exp Anim       Date:  2016-06-21

5.  The protective effect of hesperidin on methotrexate-induced intestinal epithelial damage in rats: an experimental study.

Authors:  Can Acipayam; Ibrahim Bayram; Kenan Daglioglu; Figen Doran; Sema Yilmaz; Gülay Sezgin; Berna Totan Ateş; Ayşe Ozkan; Atila Tanyeli
Journal:  Med Princ Pract       Date:  2013-11-12       Impact factor: 1.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.